Maha S. Othman

St. Lawrence College
Kingston, ON, Canada

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 129 publications

Red Blood Cells in Hemostasis and Thrombosis: Mechanisms, Interactions, and Clinical Implications.

Red Blood Cells in Hemostasis and Thrombosis: Mechanisms, Interactions, and Clinical Implications.

Journal: Seminars in thrombosis and hemostasis

Published: June 23, 2026

Designing the Future of Hemostasis.

Designing the Future of Hemostasis.

Journal: Seminars in thrombosis and hemostasis

Published: June 01, 2026

Designing the Future of Hemostasis.

Designing the Future of Hemostasis.

Journal: Seminars in thrombosis and hemostasis

Published: June 01, 2026

Erythrocyte Heterogeneity as a Driver of Thrombus Architecture and Treatment Response.

Erythrocyte Heterogeneity as a Driver of Thrombus Architecture and Treatment Response.

Journal: Seminars in thrombosis and hemostasis

Published: May 26, 2026

Red Blood Cell Biomechanics and Cancer-Associated Thrombosis.

Red Blood Cell Biomechanics and Cancer-Associated Thrombosis.

Journal: Seminars in thrombosis and hemostasis

Published: May 12, 2026

Global Multicenter Study Establishing the Reference Range for ISTH-BAT Bleeding Scores in Individuals Under 18 Years: Communication from the SSC of the ISTH.

Global Multicenter Study Establishing the Reference Range for ISTH-BAT Bleeding Scores in Individuals Under 18 Years: Communication from the SSC of the ISTH.

Journal: Journal of thrombosis and haemostasis : JTH

Published: March 18, 2026

Evaluation of Red Blood Cell Biomechanics in the Setting of Cancer-Associated Anemia and Chemotherapy.

Evaluation of Red Blood Cell Biomechanics in the Setting of Cancer-Associated Anemia and Chemotherapy.

Journal: Microcirculation (New York, N.Y. : 1994)

Published: March 10, 2026

Von Willebrand, factor VIII, and D-dimer levels as predictors of risk and clinical outcomes in acute myeloid leukemia.

Von Willebrand, factor VIII, and D-dimer levels as predictors of risk and clinical outcomes in acute myeloid leukemia.

Journal: Clinical and experimental medicine

Published: January 30, 2026

Reducing mortality, improving outcomes, and establishing equity for women with classical haematological disease: a Lancet Haematology Commission.

Reducing mortality, improving outcomes, and establishing equity for women with classical haematological disease: a Lancet Haematology Commission.

Journal: The Lancet. Haematology

Published: December 22, 2025

Management of women with type 2B von Willebrand disease during pregnancy and postpartum: guidance from ISTH SSC subcommittees on von Willebrand factor and women's health issues in thrombosis and hemostasis.

Management of women with type 2B von Willebrand disease during pregnancy and postpartum: guidance from ISTH SSC subcommittees on von Willebrand factor and women's health issues in thrombosis and hemostasis.

Journal: Journal of thrombosis and haemostasis : JTH

Published: December 11, 2025

Optimal Cutoff for the Neutrophil-to-Lymphocyte Ratio as a Tool for Pre-chemotherapy Prognosis Stratification of Breast Cancer Patients.

Optimal Cutoff for the Neutrophil-to-Lymphocyte Ratio as a Tool for Pre-chemotherapy Prognosis Stratification of Breast Cancer Patients.

Journal: Cureus

Published: August 21, 2025

Machine Learning in Venous Thromboembolism-Why and What Next?

Machine Learning in Venous Thromboembolism-Why and What Next?

Journal: Seminars in thrombosis and hemostasis

Published: August 19, 2025

Showing 1-12 of 129

Last Updated: 09/26/2026